Myeloma Bone Disease

被引：1
|
作者：
Sanderson, Ralph D. [1 ,2 ]
Epstein, Joshua [3 ]
机构：
[1] Univ Alabama Birmingham, Dept Pathol, Ctr Metab Bone Dis, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA
[3] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Dept Med, Little Rock, AR 72205 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2009年 / 24卷 / 11期
关键词：
KAPPA-B LIGAND; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; CARBOXY-TERMINAL TELOPEPTIDE; SOLUBLE RECEPTOR ACTIVATOR; I COLLAGEN ICTP; MULTIPLE-MYELOMA; BIOCHEMICAL MARKERS; OSTEOBLAST DIFFERENTIATION; MARROW MICROENVIRONMENT; GROWTH-FACTOR;
D O I：
10.1359/JBMR.090901
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1783 / 1788
页数：6
相关论文
共 50 条
  • [41] Myeloma bone disease: pathophysiology and management
    Terpos, E
    Dimopoulos, MA
    ANNALS OF ONCOLOGY, 2005, 16 (08) : 1223 - 1231
  • [42] Myeloma bone disease: Pathophysiology and management
    Silbermann, Rebecca
    Roodman, G. David
    JOURNAL OF BONE ONCOLOGY, 2013, 2 (02): : 59 - 69
  • [43] Pathogenesis and management of myeloma bone disease
    Christoulas, Dimitrios
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (04) : 385 - 398
  • [44] Myeloma bone disease and treatment options
    Yeh, Howard S.
    Berenson, James R.
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (11) : 1554 - 1563
  • [45] Novel targets for myeloma bone disease
    Roodman, G. David
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (11) : 1377 - 1387
  • [46] A neurotrophin axis in myeloma bone disease
    Pearse, RN
    Sordillo, EM
    Liau, DF
    Li, YY
    Firme, L
    Lee, R
    Rafii, D
    Hempstead, BL
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1567 - 1567
  • [47] Therapeutic targets in myeloma bone disease
    Marino, Silvia
    Petrusca, Daniela N.
    Roodman, G. David
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (09) : 1907 - 1922
  • [48] Lytic bone disease: A promoter of myeloma disease progression
    Epstein, J
    Yaccoby, S
    Yin, L
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1565 - 1566
  • [49] Bone Turnover Biomarkers Are Useful In Monitoring Myeloma Bone Disease and As Early Predictor Biomarkers For Relapse Disease In Multiple Myeloma
    Ting, Kay Reen
    Hameed, Abdul
    Brady, Jennifer
    Dowling, Paul
    Clarke, Colin
    Meiller, Justine
    Mitsiades, Constantine S.
    Richardson, Paul G.
    Anderson, Kenneth C.
    Clynes, Martin
    O'Gorman, Peter
    BLOOD, 2013, 122 (21)
  • [50] Novel Anti-Myeloma Agents and Bone Metabolism: Implications in the Management of Myeloma Bone Disease
    Terpos, Evangelos
    Christoulas, Dimitrios
    Kastritis, Efstathios
    Migkou, Magda
    Gavriatopoulou, Maria
    Dimopoulos, Meletios-Athanassios
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S30 - S32
12345